Stock ANIX ANIXA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Anixa Biosciences, Inc.

Equities

ANIX

US03528H1095

Real-time Estimate Cboe BZX
Other stock markets
 12:59:12 2024-04-19 pm EDT 		5-day change 1st Jan Change
3.1 USD 0.00% Intraday chart for Anixa Biosciences, Inc. -1.58% -19.59%
Apr. 18 Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board CI
Mar. 12 Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI

Evolution of the average Target Price on Anixa Biosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d87b533828f1f319ffa08e8ed1.GYiG3-xJYfcCoc-fQbaRuCG_CoUk7cjXEwWQ0QPkRcM.WP_Q7qYwC5Fd8Z-nA93h9VHYPuBevq2nInzWnm68Bohw4LOu2XgGpFqMhg~6fc3a7954505292f95a889e9bcfbea1b

Analyst Recommendations on Anixa Biosciences, Inc.

North American Morning Briefing : Nasdaq Futures Slip as Rate Rise Fears Weigh DJ
HC Wainwright Adjusts Price Target on Anixa Biosciences to $12 From $11, Keeps Buy Rating MT
Chardan Adjusts Price Target on Anixa Biosciences to $9 From $8, Keeps Buy Rating MT
Chardan Initiates Anixa Biosciences With Buy Rating, $8 Price Target MT
ANIXA BIOSCIENCES : HC Wainwright Starts Anixa Biosciences at Buy with $11 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.1 USD
Average target price
12 USD
Spread / Average Target
+287.10%
High Price Target
12 USD
Spread / Highest target
+287.10%
Low Price Target
12 USD
Spread / Lowest Target
+287.10%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Anixa Biosciences, Inc.

HC Wainwright
Chardan Research

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ANIX Stock
  4. Consensus Anixa Biosciences, Inc.